[COVID-19患者的胃肠道表现和肝脏疾病]
Elmer Vázquez-Cruz1, Jorge Alonso Garay-Ortega1, Aleida Bautista-Santos1
1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Departamento de Gastroenterología. Ciudad de México, México.
Revista medica del Instituto Mexicano del Seguro Social
|November 27, 2024
概括
COVID-19通常会导致胃肠道和肝脏问题. 这项研究发现,71%的住院患者经历了这些症状,腹是最常见的.
科学领域:
- 传染性疾病 传染性疾病
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行,从2019年底开始在全球迅速蔓延.
- 虽然主要以呼吸系统症状而闻名,但COVID-19也呈现出胃肠道和肝脏表现.
- 墨西哥首例病例报告于2020年3月,一些患者表现出非呼吸道症状.
研究的目的:
- 调查COVID-19患者中胃肠道表现的患病率和特征.
- 在住院患者中描述与COVID-19相关的肝脏变化.
- 分析这些症状在墨西哥的第三级护理医院环境.
主要方法:
- 进行了一项横截面的观察性研究.
- 包括84名18岁或以上的住院患者,通过PCR确认了SARS-CoV-2感染.
- 收集的数据包括人口统计,并发症和临床表现.
主要成果:
- 这项研究包括84名患者 (65%男性,平均年龄59岁) 患有常见的并发症,如高血压,糖尿病和肥胖症.
- 在45% (AST升高),42% (ALT升高),34% (GGT升高) 和13% (FA升高) 的患者中观察到肝细胞损伤.
- 胃肠道症状在71%的患者中普遍存在,腹 (53%) 和腹 (36.9%) 是最常见的. 在10%的病例中,腹之前出现呼吸道症状.
结论:
- 胃肠道和肝脏表现在住院的COVID-19患者中很常见,在71%的病例中发生.
- 腹是观察到的最常见的胃肠道症状.
- 这些发现强调了在COVID-19诊断和管理中考虑非呼吸系统症状的重要性.
更多相关视频
相关概念视频
Gastritis III: Clinical Manifestations and Management
158
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158
Diseases of the Liver and Gallbladder
475
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
475
Inflammatory Bowel Disease I: Ulcerative Colitis
138
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
138
Other Disorders of Digestive System
711
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
711
Gastritis-II: Pathophysiology
253
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
253
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46


